Drug Liability Attorneys in New York City and Nationally
Pradaxa (dabigatran etexilate) is a blood thinner that has been linked with an increased risk of internal bleeding and hemorrhaging. Known also as dabigatran etexilate and sold by Boehringer Ingelheim, it is prescribed to help reduce the risk of stroke due to atrial fibrillation.
If you or someone you know has suffered due to taking this drug and suffering from a bleeding or hemorrhaging disorder, the lawyers at Rheingold, Valet, Rheingold, McCartney & Giuffra LLP are here to help you explore your legal options.
Contact us today online or by telephone at 888-335-9457 to speak with a knowledgeable New York pharmaceutical litigation law firm.
Pradaxa and Internal Bleeding
At Rheingold, Valet, Rheingold, McCartney & Giuffra LLP, we have been helping people from New York and across the nation with their most critical legal problems for over 30 years. We are able to handle a wide range of drug liability claims, including those involving the prescription Pradaxa
Use of Pradaxa was first associated with uncontrolled bleeding while being used in elderly patients in New Zealand. This news was in September, 2011, at which time it was further discovered that the bleeding was uncontrollable. With other drugs, such as warfarin, bleeding was easy to stem by using vitamin K. However, this is not so with Pradaxa, leading to life-threatening consequences. Similar reports occurred in Japan, and the Cleveland Clinic also confirmed these problems in early 2012.
Our attorneys will work with you personally to determine the extent of the monetary damage this drug has caused you, and what legal remedies are at your disposal. Our goal is to help you obtain monetary compensation for the financial hardships you face.
Contact Us for a Case Evaluation
Have you or someone close to you been harmed by the prescription drug Pradaxa? Please contact us today online or by telephone at 888-335-9457 to speak with an experienced New York dangerous drugs liability law firm. Our law office is conveniently located in a brownstone in Midtown Manhattan located at 113 East 37th Street.
For more information, please visit our drugs and medical devices information center.